Related Experiment Video

Updated: May 4, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

21.6K

Hepatitis C virus infection in patients with nonalcoholic chronic liver disease

J M Sánchez-Tapias1, J M Barrera, J Costa

  • 1University of Barcelona, Spain.

Annals of Internal Medicine
|June 15, 1990
PubMed

Insights

Hepatitis C virus (HCV) antibodies are highly prevalent in cryptogenic liver disease, suggesting a significant role in its etiology. Testing for anti-HCV aids in distinguishing viral from autoimmune liver conditions.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Nonalcoholic chronic liver diseases encompass various etiologies, including cryptogenic liver disease and chronic hepatitis B.
  • Differentiating viral from autoimmune causes is crucial for appropriate patient management.
  • The role of hepatitis C virus (HCV) in nonalcoholic liver disease requires further investigation.

Purpose of the Study:

  • To determine the prevalence of antibodies to the hepatitis C virus (HCV) in patients with nonalcoholic chronic liver diseases.
  • To explore the etiological significance of HCV infection in cryptogenic liver disease and chronic hepatitis B.
  • To assess the utility of anti-HCV testing in differentiating viral from autoimmune chronic liver diseases.

Main Methods:

  • A cross-sectional study was conducted at a university hospital's liver unit.
  • Three hundred forty-six patients with various chronic liver diseases and 1495 healthy blood donors were enrolled.
  • Anti-HCV antibodies were detected using a newly developed enzyme-linked immunoassay.

Main Results:

  • The prevalence of anti-HCV in cryptogenic liver disease was 82%, significantly higher in patients with a history of blood transfusion.
  • Anti-HCV were detected in 11% of chronic hepatitis B patients with detectable HBV DNA and 29% with undetectable HBV replication.
  • The prevalence of anti-HCV in healthy blood donors was 1.2%.

Conclusions:

  • HCV infection likely plays a significant etiological role in cryptogenic liver disease.
  • HCV may contribute to the pathogenesis of chronic hepatitis B in a subset of patients.
  • Anti-HCV testing is a valuable tool for differentiating viral from autoimmune chronic liver diseases.
Abstract

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

13.1K

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42